Note: Perrigo's revenues are gauged from an analysis of company filings.
Perrigo's Income Statement (based on Industry Averages)
Perrigo P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Perrigo is developing and marketing.
Perrigo doesn't have any recent trademark applications, indicating Perrigo is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
DREAM FIT Oral sealing device to mitigate air loss through the mouth while using continuous positive airway pressure (CPAP) for sleep apnea treatment
02/21/2022
CLINDETS Pharmaceutical products for the treatment of acne
12/30/2020
DUAL ACTIVE Oral analgesics
12/02/2020
See all trademarks and details in the Full Report.
Market Share of Perrigo's Largest Competitors
A competitive analysis shows these companies are in the same general field as Perrigo, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Perrigo.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Perrigo and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
